Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care

Background: People with known risk factors for chronic obstructive pulmonary disease (COPD) are important targets for screening and early intervention. We sought to measure the prevalence of COPD among such individuals visiting a primary care practitioner for any reason. We also evaluated the accuracy of prior diagnosis or nondiagnosis of COPD and identified associated clinical characteristics. Methods: We recruited patients from three primary care sites who were 40 years or older and had a smoking history of at least 20 pack-years. Participants were asked about respiratory symptoms and underwent postbronchodilator spirometry. COPD was defined as a ratio of forced expiratory volume in the first second of expiration to forced vital capacity (FEV1/FVC) of less than 0.7 and an FEV1 of less than 80% predicted. Results: Of the 1459 patients who met the study criteria, 1003 (68.7%) completed spirometry testing. Of these, 208 were found to have COPD, for a prevalence of 20.7% (95% confidence interval 18.3%–23.4%). Of the 205 participants with COPD who completed the interview about respiratory symptoms before spirometry, only 67 (32.7%) were aware of their diagnosis before the study. Compared with patients in whom COPD had been correctly diagnosed before the study, those in whom COPD had been over-diagnosed or undiagnosed were similar in terms of age, sex, current smoking status and number of visits to a primary care practitioner because of a respiratory problem. Interpretation: Among adult patients visiting a primary care practitioner, as many as one in five with known risk factors met spirometric criteria for COPD. Underdiagnosis of COPD was frequent, which suggests a need for greater screening of at-risk individuals. Knowledge of the prevalence of COPD will help plan strategies for disease management.

[1]  P. Jones,et al.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.

[2]  N. Choudry,et al.  Early Detection and Impaired Quality of Life in COPD GOLD Stage 0: A Pilot Study , 2007, COPD.

[3]  J. Bourbeau,et al.  Promoting effective self-management programmes to improve COPD , 2009, European Respiratory Journal.

[4]  T. Greenhalgh,et al.  Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial , 2008, BMJ : British Medical Journal.

[5]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[6]  L. Davies,et al.  Effect of primary-care spirometry on the diagnosis and management of COPD , 2006, European Respiratory Journal.

[7]  D. Górecka,et al.  Smokers with airway obstruction are more likely to quit smoking , 2006, Thorax.

[8]  F. Maltais,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. , 2003, Canadian respiratory journal.

[9]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[10]  Victor A Kiri,et al.  Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. , 2009, Respiratory medicine.

[11]  A. Menezes,et al.  Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. , 2008, Respiratory care.

[12]  Shengming Liu,et al.  Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. , 2007, American journal of respiratory and critical care medicine.

[13]  F. Rengo,et al.  Do GOLD stages of COPD severity really correspond to differences in health status? , 2003, European Respiratory Journal.

[14]  P. Jakobsson,et al.  The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD , 2006, Scandinavian journal of primary health care.

[15]  D. Mannino,et al.  Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.

[16]  A. Gulsvik,et al.  Post-bronchodilator spirometry reference values in adults and implications for disease management. , 2006, American journal of respiratory and critical care medicine.

[17]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[18]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[19]  K. R. Chapman,et al.  Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[20]  A. Buist Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.

[21]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[22]  D. Mannino,et al.  Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. , 2006, Respiratory medicine.

[23]  Sean Keenan,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.

[24]  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. , 1997, Thorax.

[25]  S. Aaron,et al.  Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. , 2006, Chest.

[26]  Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.

[27]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[28]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[29]  C. van Weel,et al.  Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care , 2008, European Respiratory Journal.

[30]  R. West,et al.  Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample , 2006, Thorax.

[31]  K. Wood,et al.  FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. , 2006, Chest.

[32]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[33]  J. Zieliński,et al.  Early detection of COPD in a high-risk population using spirometric screening. , 2001, Chest.

[34]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[35]  D. Forman,et al.  Delays in managing lung cancer. , 2004, Thorax.

[36]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.